Guanfacine

Basic Information

Item Value
DrugBank ID DB01018
Evidence Level L5 (Computational Prediction)
Number of Predicted Indications 27

Predicted Indications (TxGNN)

The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.

# Indication Source
1 faciodigitogenital syndrome KG + DL
2 specific developmental disorder KG + DL
3 chondromyxoid fibroma KG + DL
4 trichotillomania KG + DL
5 manic bipolar affective disorder KG + DL
6 restless legs syndrome KG + DL
7 Tourette syndrome KG + DL
8 variably protease-sensitive prionopathy KG + DL
9 migraine disorder KG + DL
10 migraine with brainstem aura KG + DL
11 hypotrichosis simplex of the scalp KG + DL
12 congenital hypotrichosis milia KG + DL
13 major affective disorder KG + DL
14 diffuse alopecia areata KG + DL
15 primary hereditary glaucoma KG + DL
16 cerebellar ataxia KG + DL
17 transient tic disorder KG + DL
18 obsolete bundle branch block KG + DL
19 autosomal dominant cerebellar ataxia KG + DL
20 open-angle glaucoma KG + DL
21 tic disorder KG + DL
22 sinoatrial node disease KG + DL
23 alopecia KG + DL
24 sinoatrial block KG + DL
25 spinocerebellar degeneration with slow eye movements KG + DL
26 distal 17p13.3 microdeletion syndrome KG + DL
27 schizophrenia KG + DL

Disclaimer

These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.


← Back to Drug Search


Copyright © 2026 藥提醒科技有限公司 (yao.care). This report is for research purposes only and does not constitute medical advice.

This site uses Just the Docs, a documentation theme for Jekyll.